E-Care Breast Cancer Risk Assessment Study

Date Added
August 27th, 2025
PRO Number
Pro00145415
Researcher
Sarah Marrison

List of Studies


Keywords
Cancer/Breast, Women's Health
Summary

We will evaluate the ability of a technology-based intervention E-Care to improve communication of information about breast cancer risk and improve discussion about breast cancer screening in the primary care setting. Women ages 25-75 seen by their primary care clinician are potentially eligible to participate. Study activities include completion of a health questionnaire, reviewing a video on breast cancer screening, completion of a post-visit survey, and potential opportunity for a brief interview.

Institution
MUSC
Recruitment Contact
Mattie Banks
843-876-2926
banksmat@musc.edu

Double-blind randomized controlled trial comparing Suvorexant 20 mg to placebo for treatment of insomnia in cancer survivors

Date Added
November 14th, 2023
PRO Number
Pro00130637
Researcher
Sarah Marrison

List of Studies


Keywords
Cancer/Breast
Summary

The proposed research study evaluates the potential of an oral FDA-approved medication, suvorexant, as compared with a placebo control to improve symptoms of sleep disturbance and insomnia in breast cancer survivors currently on hormonal based therapies. Eligible participants will randomly be selected to receive either the suvorexant or a placebo control for a duration of 4 Weeks. Participation in the study will include a screening process for eligibility including information on medical history and surveys regarding symptoms at the start of the study and additionally at 2 and 4 weeks. Potential benefits include improved sleep for individuals randomized to the study medication and potential study risks include loss of confidentiality of health information and a risk of sedation and complex sleep behaviors associated with the medication, suvorexant.

Institution
MUSC
Recruitment Contact
Mattie Banks
856-876-2926
banksmat@musc.edu

Internet-delivered Management of Pain Among Cancer Treatment Survivors (IMPACTS)

Date Added
April 12th, 2021
PRO Number
Pro00109105
Researcher
Sarah Marrison

List of Studies


Keywords
Cancer, Pain
Summary

The study is being done to find out if this approach (8 sessions of the Internet-based program with education) is better or worse than the usual approach plus education only for cancer-related pain. The usual approach is defined as care most people get for cancer-related pain.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
(843) 792-9321
hcc-clinical-trials@musc.edu



-- OR --